467
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

Efficacy and Safety of Dietary Undenatured Type II Collagen on Joint and Motor Function in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & show all
Pages 224-241 | Received 07 Dec 2021, Accepted 28 Dec 2021, Published online: 21 Mar 2022

References

  • GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1789–858. doi:10.1016/S0140-6736(18)32279-7.
  • Safiri S, Kolahi A-A, Smith E, Hill C, Bettampadi D, Mansournia MA, Hoy D, Ashrafi-Asgarabad A, Sepidarkish M, Almasi-Hashiani A, Collins G, et al. Global, regional and national burden of osteoarthritis 1990-2017: a systematic analysis of the Global Burden of Disease Study 2017. Ann Rheum Dis. 2020;79(6):819–28. doi:10.1136/annrheumdis-2019-216515.
  • Yoshimura N, Muraki S, Oka H, Mabuchi A, En-Yo Y, Yoshida M, Saika A, Yoshida H, Suzuki T, Yamamoto S, et al. Prevalence of knee osteoarthritis, lumbar spondylosis, and osteoporosis in Japanese men and women: the research on osteoarthritis/osteoporosis against disability study. J Bone Miner Metab. 2009;27(5):620–8. doi:10.1007/s00774-009-0080-8.
  • Yoshimura N, Muraki S, Oka H, Kawaguchi H, Nakamura K, Akune T. Cohort profile: research on osteoarthritis/osteoporosis against disability study. Int J Epidemiol. 2010;39(4):988–95. doi:10.1093/ije/dyp276.
  • Nakamura K . A “super-aged” society and the “locomotive syndrome”. J Orthop Sci. 2008;13(1):1–2. doi:10.1007/s00776-007-1202-6.
  • Ohta K, Takao Y, Suzuki N, Yamashita S, Takara T. Effect of glucosamine HCl ingestion on human knee pain and knee-related QOL—a randomized, double-blind, placebo-controlled, parallel group trial. J New Rem Clin. 2016;65(7):946–56.
  • Tomonaga A, Fukagawa M, Suzuki A, Kurokawa M, Nagaoka I. Evaluation of the effect of N-acetyl glucosamine administration on biomarkers for cartilage metabolism in healthy individuals: a randomized double-blind placebo-controlled clinical study. FFHD. 2017;7(8):604–27. doi:10.31989/ffhd.v7i8.366.
  • Lugo JP, Saiyed ZM, Lau FC, Molina JPL, Pakdaman MN, Shamie AN, Udani JK. Undenatured type II collagen (UC-II®) for joint support: a randomized, double-blind, placebo-controlled study in healthy volunteers. J Int Soc Sports Nutr. 2013;10(1):48. doi:10.1186/1550-2783-10-48.
  • Takamizawa N, Shioya N, Nagaoka H, Uchino T. Effects and safety of a dietary supplement containing hyaluronic acid derived from chicken combs on knee pain, stiffness and discomfort—a randomized, double-blind, placebo-controlled, parallel-group comparison study. Jpn Pharmacol Ther. 2016;44(2):207–17.
  • Najima M, Munekata M, Soeda Y. Usefulness of the supplement containing proteoglycan for Japanese healthy people feeling knee’s discomfort. Med Cons New-Remed. 2016;53(3):228–36.
  • Raj JP, Venkatachalam S, Racha P, Bhaskaran S, Amaravati RS. Effect of Turmacin supplementation on joint discomfort and functional outcome among healthy participants—a randomized placebo-controlled trial. Complement Ther Med. 2020;53:102522. doi:10.1016/j.ctim.2020.102522.
  • Yoshinari O, Moriyama H, Shiojima Y, Miyawaki H. Safety and efficacy of NEXT-II®, a novel water-soluble, undenatured type II collagen in healthy human subjects suffering from occasional knee joint pain. FFHD. 2015;5(7):251–64. doi:10.31989/ffhd.v5i7.187.
  • Yoshinari O, Marone PA, Moriyama H, Bagchi M, Shiojima Y. Safety and toxicological evaluation of a novel, water-soluble undenatured type II collagen. Toxicol Mech Methods. 2013;23(7):491–9. doi:10.3109/15376516.2013.781255.
  • Marone PA, Lau FC, Gupta RC, Bagchi M, Bagchi D. Safety and toxicological evaluation of undenatured type II collagen. Toxicol Mech Methods. 2010;20(4):175–89. doi:10.3109/15376511003646440.
  • Yoshinari O, Moriyama H, Shiojima Y. An overview of a novel, water-soluble undenatured type II collagen (NEXT-II). J Am Coll Nutr. 2015;34(3):255–62. doi:10.1080/07315724.2014.919541.
  • Trentham DE, Dynesius-Trentham RA, Orav EJ, Combitchi D, Lorenzo C, Sewell KL, Hafler DA, Weiner HL. Effects of oral administration of type II collagen on rheumatoid arthritis. Science. 1993;261(5129):1727–30. doi:10.1126/science.8378772.
  • Mehra A, Anand P, Borate M, Pal P, Kamble S, Mehta KD, Qamra A, Shah A, Jain R. A non-interventional, prospective, multicentric real life Indian study to assess safety and effectiveness of un-denatured type 2 collagen in management of osteoarthritis. Int J Res Orthop. 2019;5(2):315–20. doi:10.18203/issn.2455-4510.IntJResOrthop20190798.
  • Weiner HL, da Cunha AP, Quintana F, Wu H. Oral tolerance. Immunol Rev. 2011;241(1):241–59. doi:10.1111/j.1600-065X.2011.01017.x.
  • Gupta RC, Canerdy TD, Lindley J, Konemann M, Minniear J, Carroll BA, Hendrick C, Goad JT, Rohde K, Doss R, et al. Comparative therapeutic efficacy and safety of type-II collagen (uc-II), glucosamine and chondroitin in arthritic dogs: pain evaluation by ground force plate. J Anim Physiol Anim Nutr. 2012;96(5):770–7. doi:10.1111/j.1439-0396.2011.01166.x.
  • Gustafsson T. 2005. Asymmetric synthesis of C-glycosylated amino acids—incorporation in collagen glycopeptides and evaluation in a model for rheumatoid arthritis. Umea (Sweden): VMC–KBC Umea University.
  • Yoshinari O, Shiojima Y, Moriyama H, Shinozaki J, Nakane T, Masuda K, Bagchi M. Water-soluble undenatured type II collagen ameliorates collagen-induced arthritis in mice. J Med Food. 2013;16(11):1039–45. doi:10.1089/jmf.2013.2911.
  • Nagler-Anderson C, Bober LA, Robinson ME, Siskind GW, Thorbecke GJ. Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen. Proc Natl Acad Sci USA. 1986;83(19):7443–6. doi:10.1073/pnas.83.19.7443.
  • Tong T, Zhao W, Wu Y-Q, Chang Y, Wang Q-T, Zhang L-L, Wei W. Chicken type II collagen induced immune balance of main subtype of helper T cells in mesenteric lymph node lymphocytes in rats with collagen-induced arthritis. Inflamm Res. 2010;59(5):369–77. doi:10.1007/s00011-009-0109-4.
  • Chondrex Inc., Type II Collagen Detection Kit. Multi-Species, Catalog No. 6018. 2020 Chondrex Inc. https://www.chondrex.com/products/type-ii-collagen-detection-kit-multi-species2
  • Akai M, Doi T, Fujino K, Iwaya T, Kurosawa H, Nasu T. An outcome measure for Japanese people with knee osteoarthritis. J Rheumatol. 2005;32(8):1524–32.
  • Iida S, Aoki C. Reliability of the 10-meter walking test [Part 1]: influence of different measurement orders on the fastest walking and normal walking. Rigakuryoho Kagaku. 2017;32(1):81–4. doi:10.1589/rika.32.81.
  • Shirado O, Doi T, Akai M, Fujino K, Hoshino Y, Iwaya T. Development of new disease-specific QOL measure for patients with chronic low back pain: Japan Low back pain Evaluation Questionnaire (JLEQ). J Lumbar Spine Disord. 2007;13(1):225–35. doi:10.3753/yotsu.13.225.
  • Wolfe F, Hawley DJ, Peloso PM, Wilson K, Anderson J. Back pain in osteoarthritis of the knee. Arthritis Care Res. 1996;9(5):376–83. doi:10.1002/1529-0131(199610)9:5<376::AID-ANR1790090506>3.0.CO;2-1.
  • Muraki S, Akune T, Oka H, Mabuchi A, En-Yo Y, Yoshida M, Saika A, Nakamura K, Kawaguchi H, Yoshimura N. Association of occupational activity with radiographic knee osteoarthritis and lumbar spondylosis in elderly patients of population-based cohorts: a large-scale population-based study. Arthritis Rheum. 2009;61(6):779–86. doi:10.1002/art.24514.
  • Iijima H, Suzuki Y, Aoyama T, Takahashi M. Interaction between low back pain and knee pain contributes to disability level in individuals with knee osteoarthritis: a cross-sectional study. Osteoarthritis Cartilage. 2018;26(10):1319–25. doi:10.1016/j.joca.2018.06.012.
  • Yabe Y, Hagiwara Y, Sekiguchi T, Momma H, Tsuchiya M, Kuroki K, Kanazawa K, Koide M, Itaya N, Yoshida S, et al. Knee pain is associated with lower back pain in young baseball players: a cross-sectional study. Knee Surg Sports Traumatol Arthrosc. 2019;27(3):985–90. doi:10.1007/s00167-018-5129-6.
  • Okabe D, Tsuji T, Hanazato M, Miyaguni Y, Asada N, Kondo K. Neighborhood walkability in relation to knee and low back pain in older people: a multilevel cross-sectional study from the JAGES. Int J Environ Res Public Health. 2019;16(23):4598. doi:10.3390/ijerph16234598.
  • Serrao PRMS, Gramani-Say K, Lessi GC, Mattiello SM. Knee extensor torque of men with early degrees of osteoarthritis is associated with pain, stiffness and function. Rev Bras Fisioter. 2012;16(4):289–94. doi:10.1590/S1413-35552012005000031.
  • Heiden TL, Lloyd DG, Ackland TR. Knee extension and flexion weakness in people with knee osteoarthritis: is antagonist cocontraction a factor? J Orthop Sports Phys Ther. 2009;39(11):807–15.
  • Corthay A, Backlund J, Broddefalk J, Michaelsson E, Goldschmidt TJ, Kihlberg J, Holmdahl R. Epitope glycosylation plays a critical role for T cell recognition of type II collagen in collagen-induced arthritis. Eur J Immunol. 1998;28(8):2580–90. doi:10.1002/(SICI)1521-4141(199808)28:08<2580::AID-IMMU2580>3.0.CO;2-X.
  • Bagchi D, Misner B, Bagchi M, Kothari SC, Downs BW, Fafard RD, Preuss HG. Effects of orally administered undenatured type II collagen against arthritic inflammatory diseases: a mechanistic exploration. Int J Clin Pharm Res. 2002;22(3-4):101–10.
  • Hattori S, Ebihara T, Amano M, Sato C, Irie S. Comparative biology of collagens extracted from various tissues of diverse animal species. Fragr J. 2001;29(11):52–8.
  • Park K-S, Park M-J, Cho M-L, Kwok S-K, Ju JH, Ko H-J, Park S-H, Kim H-Y. Type II collagen oral tolerance; mechanism and role in collagen-induced arthritis and rheumatoid arthritis. Mod Rheumatol. 2009;19(6):581–9. doi:10.3109/s10165-009-0210-0.
  • Trentham DE, Halpner AD, Trentham RA, Bagchi M, Kothari S, Preuss HG, Bagchi D. Use of undenatured type II collagen in the treatment of rheumatoid arthritis. Clin Prac Alter Med. 2001;2(4):254–9.
  • Chen Y, Kuchroo VK, Inobe J, Hafler DA, Weiner HL. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science. 1994;265(5176):1237–40. doi:10.1126/science.7520605.
  • Muller RD, John T, Kohl B, Oberholzer A, Gust T, Hostmann A, Hellmuth M, LaFace D, Hutchins B, Laube G, et al. IL-10 overexpression differentially affects cartilage matrix gene expression in response to TNF-alpha in human articular chondrocytes in vitro. Cytokine. 2008;44(3):377–85. doi:10.1016/j.cyto.2008.10.012.
  • Suzukamo C, Ishimaru K, Ochiai R, Osaki N, Kato T. Milk-fat globule membrane plus glucosamine improves joint function and physical performance: a randomized, double-blind, placebo-controlled, parallel-group study. J Nutr Sci Vitaminol. 2019;65(3):242–50. doi:10.3177/jnsv.65.242.
  • Suri P, Morgenroth DC, Kwoh CK, Bean JF, Kalichman L, Hunter DJ. Low back pain and other musculoskeletal pain comorbidities in individuals with symptomatic osteoarthritis of the knee: data from the osteoarthritis initiative. Arthritis Care Res. 2010;62(12):1715–23. doi:10.1002/acr.20324.
  • Kiss RM. Effect of severity of knee osteoarthritis on the variability of gait parameters. J Electromyogr Kinesiol. 2011;21(5):695–703. doi:10.1016/j.jelekin.2011.07.011.
  • Najm WI, Reinsch S, Hoehler F, Tobis JS, Harvey PW. S-Adenosyl methionine (SAMe) versus celecoxib for the treatment of osteoarthritis symptoms: a double-blind cross-over trial. BMC Musculoskelet Disord. 2004;5(1):6. doi:10.1186/1471-2474-5-6.
  • Kanzaki N, Ono Y, Shibata H, Moritani T. Glucosamine-containing supplement improves locomotor functions in subjects with knee pain: a randomized, double-blind, placebo-controlled study. CIA. 2015;10:1743–53. doi:10.2147/CIA.S93077.
  • Iijima H, Suzuki Y, Aoyama T, Takahashi M . Relationship between varus thrust during gait and low back pain in individuals with knee osteoarthritis. Arthritis Care Res. 2020;72(9):1231–8. doi:10.1002/acr.24020.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.